• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Resurgence of human metapneumovirus infection and influenza after three seasons of inactivity in the post-COVID-19 era in Hokkaido, Ja

tetano

Editor, Senior Moderator
J Med Virol


. 2023 Dec;95(12):e29299.
doi: 10.1002/jmv.29299. Resurgence of human metapneumovirus infection and influenza after three seasons of inactivity in the post-COVID-19 era in Hokkaido, Japan, 2022-2023

Yuya Fukuda[SUP] 1 2 [/SUP], Atsuo Togashi[SUP] 1 [/SUP], Satoshi Hirakawa[SUP] 1 [/SUP], Masaki Yamamoto[SUP] 1 [/SUP], Shinobu Fukumura[SUP] 1 [/SUP], Tomohiro Nawa[SUP] 3 [/SUP], Saho Honjo[SUP] 4 [/SUP], Jun Kunizaki[SUP] 5 [/SUP], Kouhei Nishino[SUP] 6 [/SUP], Toju Tanaka[SUP] 7 [/SUP], Toshitaka Kizawa[SUP] 8 [/SUP], Dai Yamamoto[SUP] 9 [/SUP], Ryoh Takeuchi[SUP] 10 [/SUP], Yuta Sasaoka[SUP] 11 [/SUP], Masayoshi Kikuchi[SUP] 12 [/SUP], Takuro Ito[SUP] 13 [/SUP], Kazushige Nagai[SUP] 14 [/SUP], Hirofumi Asakura[SUP] 15 [/SUP], Katsumasa Kudou[SUP] 16 [/SUP], Masaki Yoshida[SUP] 17 [/SUP], Takeshi Nishida[SUP] 18 [/SUP], Takeshi Tsugawa[SUP] 1 [/SUP]



Affiliations
Abstract

Following the coronavirus disease 2019 (COVID-19) outbreak in February 2020, incidences of various infectious diseases decreased notably in Hokkaido Prefecture, Japan. However, Japan began gradually easing COVID-19 infection control measures in 2022. Here, we conducted a survey of children hospitalized with human metapneumovirus (hMPV), influenza A and B, and respiratory syncytial virus infections in 18 hospitals across Hokkaido Prefecture, Japan, spanning from July 2019 to June 2023. From March 2020 to June 2022 (28 months), only 13 patients were hospitalized with hMPV, and two patients had influenza A. However, in October to November 2022, there was a re-emergence of hMPV infections, with a maximum of 27 hospitalizations per week. From July 2022 to June 2023 (12 months), the number of hMPV-related hospitalizations dramatically increased to 317 patients, with the majority aged 3-6 years (38.2%, [121/317]). Influenza A also showed an increase from December 2022, with a peak of 13 hospitalizations per week in March 2023, considerably fewer than the pre-COVID-19 outbreak in December 2019, when rates reached 45 hospitalizations per week. These findings suggest the possibility of observing more resurgences in infectious diseases in Japan after 2023 if infection control measures continue to be relaxed. Caution is needed in managing potential outbreaks.

Keywords: COVID-19; child; human metapneumovirus; influenza; respiratory syncytial virus.

 
Back
Top Bottom